ATE216247T1 - Aromatische oligomere verbindungen als imitatoren bioaktives makromoleküle - Google Patents

Aromatische oligomere verbindungen als imitatoren bioaktives makromoleküle

Info

Publication number
ATE216247T1
ATE216247T1 AT92912715T AT92912715T ATE216247T1 AT E216247 T1 ATE216247 T1 AT E216247T1 AT 92912715 T AT92912715 T AT 92912715T AT 92912715 T AT92912715 T AT 92912715T AT E216247 T1 ATE216247 T1 AT E216247T1
Authority
AT
Austria
Prior art keywords
oligomeric compounds
disorders
immittators
treatment
bioactive macromolecules
Prior art date
Application number
AT92912715T
Other languages
English (en)
Inventor
John R Regan
Daniel G Mcgarry
Michael N Chang
Jeffrey N Barton
Jack Newman
Schmuel Ben-Sasson
Original Assignee
Rhone Poulenc Rorer Internat H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Internat H filed Critical Rhone Poulenc Rorer Internat H
Application granted granted Critical
Publication of ATE216247T1 publication Critical patent/ATE216247T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G8/00—Condensation polymers of aldehydes or ketones with phenols only
    • C08G8/04—Condensation polymers of aldehydes or ketones with phenols only of aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
  • Polyamides (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
AT92912715T 1991-05-20 1992-05-20 Aromatische oligomere verbindungen als imitatoren bioaktives makromoleküle ATE216247T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70306191A 1991-05-20 1991-05-20
PCT/US1992/004274 WO1992020350A1 (en) 1991-05-20 1992-05-20 Aromatic oligomeric compounds useful as mimics of bioactive macromolecules

Publications (1)

Publication Number Publication Date
ATE216247T1 true ATE216247T1 (de) 2002-05-15

Family

ID=24823810

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92912715T ATE216247T1 (de) 1991-05-20 1992-05-20 Aromatische oligomere verbindungen als imitatoren bioaktives makromoleküle

Country Status (8)

Country Link
EP (1) EP0585371B1 (de)
AT (1) ATE216247T1 (de)
AU (1) AU2010792A (de)
DE (1) DE69232557T2 (de)
DK (1) DK0585371T3 (de)
ES (1) ES2174834T3 (de)
MX (1) MX9202389A (de)
WO (1) WO1992020350A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE433964T1 (de) 2000-12-28 2009-07-15 Takeda Pharmaceutical Alkansäurederivate, verfahren zu deren herstellung und deren verwendung
EP1394154A4 (de) 2001-03-23 2005-05-18 Takeda Pharmaceutical Fünfgliedriges heterocyclisches alkansäurederivat
WO2005026150A1 (en) 2003-09-16 2005-03-24 Astrazeneca Ab Quinazoline derivatives as tyrosine kinase inhibitors
EP1928237A4 (de) 2005-09-02 2011-03-09 Abbott Lab Neue heterocyclen auf imidazo-basis
CN112135825A (zh) 2018-03-13 2020-12-25 夏尔人类遗传性治疗公司 血浆激肽释放酶抑制剂及其用途
CN114728962B (zh) 2019-09-18 2025-09-19 武田药品工业有限公司 血浆激肽释放酶抑制剂及其用途
WO2021055589A1 (en) 2019-09-18 2021-03-25 Shire Human Genetic Therapies, Inc. Heteroaryl plasma kallikrein inhibitors
CA3251849A1 (en) 2022-03-02 2023-09-07 Horizon Therapeutics Ireland Dac METHOD FOR MANUFACTURING A CRYSTALLINE EDG-2 RECEPTOR ANTAGONIST
AU2023228377A1 (en) 2022-03-02 2024-08-08 Horizon Therapeutics Ireland Dac Treatment of systemic sclerosis and idiopathic pulmonary fibrosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2323481A (en) * 1939-03-14 1943-07-06 Du Pont Chemical process and composition
US2910484A (en) * 1957-05-09 1959-10-27 Ciba Pharm Prod Inc Polyhydric-aldehyde condensation products
US4604404A (en) * 1985-04-03 1986-08-05 A. H. Robins Company, Inc. Antiviral sulfonated naphthalene formaldehyde condensation polymers
IL95353A (en) * 1989-08-14 1995-01-24 Rhone Poulenc Rorer Int Pharmaceutical preparations containing aromatic polymers
JPH05508665A (ja) * 1989-11-22 1993-12-02 ローヌー プーラン ローラー インターナショナル(ホウルディングス)インコーポレイテッド アルキル―またはヘテロアルキル―アリール主鎖を有するポリマー及びこれらのポリマーを含む医薬組成物
FR2672214A1 (fr) * 1991-01-31 1992-08-07 Rhone Poulenc Rorer Sa Application de polymeres biologiquement actifs, pour l'obtention d'un medicament pour le traitement d'infections a retrovirus.

Also Published As

Publication number Publication date
MX9202389A (es) 1993-08-01
DE69232557D1 (de) 2002-05-23
WO1992020350A1 (en) 1992-11-26
EP0585371A4 (en) 1994-07-13
EP0585371A1 (de) 1994-03-09
AU2010792A (en) 1992-12-30
DK0585371T3 (da) 2002-08-12
DE69232557T2 (de) 2002-10-24
ES2174834T3 (es) 2002-11-16
EP0585371B1 (de) 2002-04-17

Similar Documents

Publication Publication Date Title
IL225192A (en) Combinations of dextromethorphan and quinidine for the preparation of mental illness, neuropathic pain or brain injury
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
PT1133989E (pt) Composicoes polimericas para utilizacao em terapia
ATE298790T1 (de) Phosphatase oder ein entsprechendes derivat enthaltene pharmazeutische zusammensetzung
TW264480B (de)
ATE457166T1 (de) Orale zusammensetzungen zur behandlung von diabetes
DE60045550D1 (de) Vorbeugung und behandlung von amyloidogenischen krankheiten
BRPI0509366B8 (pt) composição farmacêutica, kit farmacêutico, e, uso de uma composição farmacêutica
PL342078A1 (en) Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
ATE350019T1 (de) Verfahren zur behandlung von kapseln und trockenen gepulverten pharmazeutischen formulierungen
IL159903A0 (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
DE19975006I2 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler St¦rungen.
DE69232557D1 (de) Aromatische oligomere verbindungen als imitatoren bioaktives makromoleküle
WO2004067027A3 (en) Osteogenic composition
DE69429856D1 (de) Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit
WO1999056666A8 (en) The treatment of sexual dysfunction in certain patient groups
ATE255411T1 (de) Hyaluronsäurerezeptoren bindende stoffe und deren verwendung zur behandlung von tumoren und restenose
DE60004093D1 (de) Pharmazeutische zusammensetzung welche riluzol und gabapentin enthält zur behandung von motoneuronalen krankheiten
GR3020232T3 (en) LOW-MOLECULAR SULPHATED POLY--g(b)-2,6-FRUCTOFURANOSANES AND THEIR USE IN THE TREATMENT OF DEGENERATIVE ARTICULAR AILMENTS
RU98114982A (ru) Состав, содержащий диосгенин
BG105763A (en) Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
TH69074A (th) แลคโทเฟอร์ริน โพลิเปปไทด์สำหรับเสริมสุขภาพกระดูกให้แข็งแรงขึ้น

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee